GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » Short Interest

SenzaGen AB (OSTO:SENZA) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is SenzaGen AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of SenzaGen AB's Short Interest

For the Diagnostics & Research subindustry, SenzaGen AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SenzaGen AB's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SenzaGen AB's Short Interest distribution charts can be found below:

* The bar in red indicates where SenzaGen AB's Short Interest falls into.


;
;

SenzaGen AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » Short Interest
Comparable Companies
OSTO:AROC NGM:LUMITO OSTO:IMMNOV XSAT:GEAN NGM:LEVBIO NGM:ATANA OSTO:PROGEN XSAT:SPERM TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Building 401, Lund, SWE, 223 81
Website
https://www.senzagen.com
SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.

SenzaGen AB Headlines

No Headlines